Log In
Print
BCIQ
Print
Print this Print this
 

Oxycodone-naltrexone (ALO-02)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionExtended-release oxycodone hydrochloride, an opioid agonist, surrounding sequestered naltrexone hydrochloride, an opioid receptor antagonist
Molecular Target Mu opioid receptor (OPRM1) (MOR)
Mechanism of ActionMu opioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationPain
Indication DetailsTreat moderate to severe chronic low back pain; Treat moderate to severe chronic, non-cancer pain
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today